E-Therapeutics PLC (GB:ETX)
LSE:ETX
Holding GB:ETX?
Track your performance easily

E Therapeutics (ETX) Technical Analysis

5 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
E-Therapeutics PLC’s (ETX) Moving Averages Convergence Divergence (MACD) indicator is -0.63, suggesting E-Therapeutics PLC is a Sell.
E-Therapeutics PLC’s (ETX) 20-Day exponential moving average is 9.91, while E-Therapeutics PLC’s (ETX) share price is 9p, making it a Sell.
E-Therapeutics PLC’s (ETX) 50-Day exponential moving average is 11.07, while E-Therapeutics PLC’s (ETX) share price is 9p, making it a Sell.

E Therapeutics (ETX) Pivot Points

Nov 10, 2024, 12:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.67
7.83
8.42
9.58
10.17
11.33
11.92
Fibonacci
7.83
8.50
8.91
9.58
10.25
10.66
11.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

E Therapeutics (ETX) Moving Averages

Nov 10, 2024, 12:46 PM
Period
Simple
Exponential
MA5
9.36Sell
9.27Sell
MA10
9.50Sell
9.48Sell
MA20
9.80Sell
9.91Sell
MA50
11.28Sell
11.07Sell
MA100
12.46Sell
11.95Sell
MA200
12.66Sell
13.20Sell
E-Therapeutics PLC’s (ETX) 10-Day exponential moving average is 9.48, while E-Therapeutics PLC’s (ETX) share price is 9p, making it a Sell.
E-Therapeutics PLC’s (ETX) 100-Day exponential moving average is 11.95, while E-Therapeutics PLC’s (ETX) share price is 9p, making it a Sell.
E-Therapeutics PLC’s (ETX) stock price is 9p and E-Therapeutics PLC’s (ETX) 50-day simple moving average is 11.28, creating a Sell signal.
E-Therapeutics PLC’s (ETX) stock price is 9p and E-Therapeutics PLC’s (ETX) 100-day simple moving average is 12.46, creating a Sell signal.
E-Therapeutics PLC’s (ETX) stock price is 9p and E-Therapeutics PLC’s (ETX) 200-day simple moving average is 12.66, creating a Sell signal.

E Therapeutics (ETX) Technical Indicators

Nov 10, 2024, 12:46 PM
Name
Value
Implied Action
RSI (14)
38.11
Neutral
STOCH (9,6)
23.01
Neutral
STOCHRSI (14)
23.58
Neutral
MACD (12,26)
-0.63
Sell
ADX (14)
19.53
Buy
Williams %R
-84.00
Buy
CCI (14)
-109.70
Buy
ATR (14)
1.17
-
Ultimate Oscillator
43.64
Neutral
ROC
-9.55
Sell
E-Therapeutics PLC’s (ETX) Relative Strength Index (RSI) is 38.11, creating a Neutral signal.
E-Therapeutics PLC’s (ETX) Trend Strength Indicator (ADX) is 19.53, creating a Buy signal.
E-Therapeutics PLC’s (ETX) Commodity Channel Index (CCI) is -109.70, creating a Buy signal.
E-Therapeutics PLC’s (ETX) Price Rate of Change (ROC) is -9.55, creating a Sell signal.

FAQ

Is ETX a Buy, Hold, or Sell?
Based on ETX’s technical indicators, ETX is a Strong Sell.
    What is ETX’s RSI (14)?
    ETX’s RSI (14) is 38.11, which suggests ETX is a Neutral.
      What is ETX’s MACD?
      ETX’s MACD is -0.63, which suggests ETX is a Sell.
        What is ETX’s 5-day moving average?
        ETX’s 5-day moving average is 9.36, which suggests ETX is a Sell.
          What is ETX’s 20-day moving average?
          ETX 20-day moving average is 9.80, which suggests ETX is a Sell.
            What is ETX’s 50-day moving average?
            ETX’s 50-day moving average is 11.28, which suggests ETX is a Sell.
              What is ETX’s 200-day moving average?
              ETX’s 200-day moving average is 12.66, which suggests ETX is a Sell.
                What is ETX’s Williams % R (14)?
                ETX’s Williams % R (14) is -84.00, which suggests ETX is a Buy.
                  What is ETX’s CCI (14)?
                  ETX’s CCI (14) is -109.70, which suggests ETX is a Buy.
                    What is the share price of E-Therapeutics PLC?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis